ISRAEL CANCER
RESEARCH FUND
The answer to cancer is research.
Since 1975, medical researchers, oncologists and lay people have been fighting for a cure for cancer via the work of ICRF to save the lives of cancer patients in Toronto, North America and throughout the world.
To date, ICRF has funded over 2,809 grants totalling more than USD $92,408,000 to major hospitals, universities and cancer research facilities throughout Israel.
This year we were able to fund USD $4.85 million dollars to 79 scientists across 11 Israeli institutions!
Grant allocations are made only to the top scientists with research projects that are vetted through our rigorous Scientific Review Panel comprised of leading oncologists and scientists in North America.
ICRF helps Israel's best and brightest scientists maintain their rightful place on the world stage bringing recognition, praise and pride to Israel.
Supporting ICRF means funding world class research.
WHY ISRAEL?
Your Gift Goes Further
Research in Israel carries less overhead than North American research & funds are allocated directly to our scientists in their labs.
Startup Nation
Israel is a global powerhouse for innovation
and entrepreneurialism.
Diversified Research
ICRF is currently funding researchers across 11 institutions in Israel working on all areas of cancer research.
"I have a naïve faith that the answer to cancer will come from Israel, because Israel has given to humanity a concept of celebrating life. What you are doing is of extraordinary meaning and importance: first of all to save lives. Is there anything more noble in the whole world?"
- Elie Weisel
OUR SUCCESSES
Doxil®
This cancer drug works overtime to treat ovarian, breast and AIDS-related cancers.
RAD 51
Used to identify the likelihood of breast cancer occurring in women who carry the BRCA 2 gene.
The Ubiquitin System
This discovery led to development of the miracle drug Velcade® for treatment of multiple myeloma.
Israel Winning the Nobel Prize
ICRF funded professors Avram Hershko and Aaron Ciechanover won for their discovery of the Ubiquitin System. Their research resulted in the development of the drug Velcade® named “The Top Medical Breakthrough of 2003” by the Wall Street Journal.
Want to learn more?
Our researchers are tirelessly working to find new treatments and cures for all forms of cancer. Learn about our new discoveries as they happen and join our ICRF Newsletter mailing list below!